MetLife Investment Management’s Xometry XMTR Stock Holding History

MetLife Investment Management’s Portfolio XMTR Stock Details XMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.01M	Buy	24,639 +219	+0.9%	+$11.6K	0.01%	1390
2025 Q4	$1.45M	Sell	24,420 -1,247	-5%	-$70.3K	0.01%	1229
2025 Q3	$1.4M	Hold	25,667	–	–	0.01%	1268
2025 Q2	$867K	Hold	25,667	–	–	0.01%	1381
2025 Q1	$640K	Sell	25,667 -419	-2%	-$13.2K	﹤0.01%	1596
2024 Q4	$1.11M	Buy	26,086 +1,241	+5%	+$35.1K	0.01%	1358
2024 Q3	$456K	Hold	24,845	–	–	﹤0.01%	1827
2024 Q2	$287K	Buy	24,845 +6,818	+38%	+$107K	﹤0.01%	2026
2024 Q1	$304K	Hold	18,027	–	–	﹤0.01%	1951
2023 Q4	$647K	Hold	18,027	–	–	﹤0.01%	1538
2023 Q3	$306K	Hold	18,027	–	–	﹤0.01%	1941
2023 Q2	$382K	Hold	18,027	–	–	﹤0.01%	1873
2023 Q1	$270K	Hold	18,027	–	–	﹤0.01%	2042
2022 Q4	$581K	Hold	18,027	–	–	﹤0.01%	1542
2022 Q3	$1.02M	Hold	18,027	–	–	0.01%	1178
2022 Q2	$612K	Buy	18,027 +4,002	+29%	+$138K	﹤0.01%	1525
2022 Q1	$515K	Buy	14,025 +10,865	+344%	+$497K	﹤0.01%	1757
2021 Q4	$162K	Hold	3,160	–	–	﹤0.01%	2184
2021 Q3	$182K	Buy	+3,160	New	+$219K	﹤0.01%	2157

Other funds holding XMTR

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

MetLife Investment Management's XMTR Position: Q1 2026 in Review

MetLife Investment Management increased its Xometry (XMTR) stake by 0.9% in Q1 2026, buying an estimated $11.6K and bringing the position to 24,639 shares worth $1.01M. The position accounts for 0.01% of the portfolio, ranked #1390.

MetLife Investment Management first reported a position in XMTR in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.45M in Q4 2025. 248 funds tracked by Wall St. Rank hold XMTR as of Q1 2026.

MetLife Investment Management held 24,639 shares of Xometry worth $1.01M as of Q1 2026.
MetLife Investment Management bought 219 Xometry shares in Q1 2026, an estimated $11.6K.
Xometry made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1390 holding.
MetLife Investment Management first reported a position in Xometry in Q3 2021 and has held it in 19 quarters since.
MetLife Investment Management's Xometry position peaked at $1.45M in Q4 2025.
248 funds tracked by Wall St. Rank held Xometry as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.